Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03279289
Title Study to Assess the Efficacy and Safety of Treatment With FOLFIRI-aflibercept Compared to Initial Treatment With FOLFIRI-aflibercept (for 6 Cycles) Followed by Maintenance With 5FU-aflibercept, in an Elderly Population With mCRC After Failure of an Oxaliplatin-based Regimen (AFEMA)
Acronym AFEMA
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Age Groups: senior
Covered Countries ESP

No variant requirements are available.